ageas SA/NV (AGS.BR)
| Previous close | 46.22 |
| Open | 46.36 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 46.20 - 46.52 |
| 52-week range | 35.66 - 48.44 |
| Volume | |
| Avg. volume | 257,218 |
| Market cap | 8.537B |
| Beta (5Y monthly) | 0.76 |
| PE ratio (TTM) | 8.03 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.25 (7.03%) |
| Ex-dividend date | 04 Dec 2024 |
| 1y target est | N/A |
- Reuters
Exclusive-Bain Capital taps advisers for sale of UK's esure, sources say
Private equity firm Bain Capital has lined up advisers for the possible sale of British motor and home insurer esure, three people familiar with the matter told Reuters. Fenchurch is among the advisers tapped for the sale, two of the people said. Potential bidders include Belgian insurer Ageas, which has said it wants to expand in UK general insurance but abandoned its pursuit of esure's larger rival Direct Line earlier this year, one of the people and third one said, speaking on condition of anonymity.
- Zacks
AGESY or RDN: Which Is the Better Value Stock Right Now?
AGESY vs. RDN: Which Stock Is the Better Value Option?
- Zacks
Is Ageas (AGESY) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
